Journals / Dicle Tıp Dergisi / 2014 / Cilt: 41 - Sayı: 4

Güneydoğu Anadolu Bölgesinde supraventriküler taşikardi ile başvuran hastaların klinik özellikleri

Clinical characteristics of the patients presented with supraventricular tachycardia in southeast Anatolian region of Turkey

Pages
623–628
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall RF ablation success rate was 96.2%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, we aimed to evaluate the characteristic of patients with supraventricular tachycardia for proper diagnosis and treatment in Southeast Anatolian region.
📊
Key Findings & Data:One hundred eighty-seven consecutive patients who underwent catheter ablation of SVT between June 2012 and April 2014 at the Dicle University Heart Hospital were included in the study.
💡
Conclusion & Impact:Overall RF ablation success rate was 96.2%.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, we aimed to evaluate the characteristic of patients with supraventricular tachycardia for proper diagnosis and treatment in Southeast Anatolian region. Methods: The study was has a retrospective cross-sectional design. One hundred eighty-seven consecutive patients who underwent catheter ablation of SVT between June 2012 and April 2014 at the Dicle University Heart Hospital were included in the study. In those patients, in whom the arrhythmia substrate was identified, ablation therapy was carried out using radiofrequency (RF) energy. Results: Among SVTs 119 (63.6%) patients had atrioventricular nodal re-entry tachycardia (AVNRT), 20 (10.7%) patients had concealed atrioventricular re-entry tachycardia (AVRT), 40 (21.4%) patients had Wolf Parkinson White (WPW) syndrome, and 8 (4.3%) patients had atrial tachycardia. RF ablation was applied on 184 patients. Overall RF ablation success rate was 96.2%. Overall recurrence was 8 (4%) of 187 patients during the followup period 12 ± 6 (1-23) months. The recurrence was 4 (3.4%) of 119 patients in AVNRT, 2(5%) of 40 patients in WPW syndrome and 2 (10%) of 20 patients in concealed AVRT. There was no statistically significant difference between groups in terms of recurrence. Two patients having AVNRT ablation died due to acute coronary syndrome in clinical follow-up. Conclusion: The acute and long-term success rates of SVT ablation were in accordance with literature. The other characteristics of SVT were similar with the current data.

Özet

Amaç: Bu çalışmamızın amacı Güneydoğu Anadolu bölgesinde supraventriküler taşikardilerin (SVT) tanı ve tedavisinin klinik özelliklerinin değerlendirilmesidir. Yöntemler: Çalışma retrospektif olarak yapıldı. Haziran 2012 ve Nisan 2014 süresinde, Dicle Üniversitesi Kalp Hastanesinde ablasyon tedavisi amacıyla kateter ablasyon laboratuarına alınan ardışık 187 hasta çalışmaya dahil edildi. Aritmi ayırıcı tanısı yapıldıktan sonra aritmi odağı radyofrekans (RF) yöntemi ile ablasyon yapıldı. Bulgular: Supraventriküler taşikardili hastaların 119u (%63,6) atriyoventriküler (AV) nodal reentran taşikardi (AVNRT), 20si (%10,7) gizli AV reentran taşikardi (AVRT), 40ı (%21,4) Wolf-Parkinson-White (WPW) sendromu ve 8 i (%4,3) atriyal taşikardi olarak saptandı. Yüz seksen dört hastaya RF ablasyon tedavisi uygulandı. Genel olarak RF ablasyon başarısı % 96,2 idi. Genel olarak 12 ± 6 (1-23 ay) aylık sürede 8 (%4) hastada nüks geliş- ti. Nüks gelişen hastaların 4 (%3,4)ü AVNRT, 2 (%5)si WPW sendromu ve 2 (%10) si gizli AVRT olduğu saptandı. Gruplar arasında nüks açısından istatiksel olarak fark yoktu. Takiplerde AVNRT ablasyonu yapılmış olan 2 hasta akut koroner sendrom nedeniyle öldüğü saptandı. Sonuç: Supraventriküler taşikardili hastaların özellikleri literatür bilgileri ile benzerlik göstermektedir ve kliniğimizde SVT hastalarının tanı ve tedavisi literatür ile uyumlu olarak başarılı bir şekilde yapılmaktadır.

🔖

Cite This Article

AYDIN, M., YILDIZ, A., AKTAN, A., POLAT, N., YÜKSEL, M., AKIL, M. A., ÖZBEK, H., İSLAMOĞLU, Y. (2014). Güneydoğu Anadolu Bölgesinde supraventriküler taşikardi ile başvuran hastaların klinik özellikleri. Dicle Tıp Dergisi, Cilt: 41 - Sayı: 4, 623–628. https://ajindex.com/articles/349544

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Walfridsson U, Strömberg A, Janzon M, Walfridsson H. Wolff-Parkinson-White syndrome and atrioventricular nodal re-entry tachycardia in a Swedish population: consequences on health-related quality of life. Pacing Clin Electrophysiol 2009;32:1299-1306
  2. Porter MJ, Morton JB, Denman R, et al. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm 2004;1:393-396
  3. Tada H, Oral H, Greenstein R, et al. Analysis of age of onset of accessory pathway-mediated tachycardia in men and women. Am J Cardiol 2002;89:470-471
  4. Delacretaz E. Supraventricular tachycardia. N Engl J Med 2006;354:1039-1051
  5. Gursoy S, Steurer G, Brugada J, et al. The hemodynamic mechanism of pounding in the neck in atrioventricular nodal reentrant tachycardia. N Engl J Med 1992;327:772-774
  6. Bathina MN, Mickelsen S, Brooks C, et al. Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs. Am J Cardiol 1998;82:589-593
  7. Goldberg AS, Bathina MN, Mickelsen S, et al. Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy). Am J Cardiol 2002;89:1120-1123
  8. Tanboğa IH, Kurt M, Işık T, et al. Catheter ablation treatment of atrioventricular nodal re-entrant tachycardia. Dicle Med J 2012;39:166-173
  9. Obeyesekere MN, Leong-Sit P, Massel D, et al. Risk of arrhythmia and sudden death in patients with asymptomatic preexcitation: a meta-analysis. Circulation 2012;125:2308- 2315
  10. Klein GJ, Bashore TM, Sellers TD, et al. Ventricular-fibrillation in the Wolff-Parkinson-White Syndrome. N Engl J Med 1979;301:1080-1085
  11. Winniford MD, Fulton KL, Hillis LD. Long-term therapy of paroxysmal supraventricular tachycardia: a randomized, double-blind comparison of digoxin, propranolol and verapamil. Am J Cardiol 1984;54:1138-1139
  12. Feldman A, Voskoboinik A, Kumar S, et al. Predictors of acute and long-term success of slow pathway ablation for atrioventricular nodal reentrant tachycardia: a single center series of 1,419 consecutive patients. Pacing Clin Electrophysiol 2011;34:927-933
  13. Stern JD, Rolnitzky L, Goldberg JD, et al. Meta-analysis to assess the appropriate endpoint for slow pathway ablation of atrioventricular nodal reentrant tachycardia. Pacing Clin Electrophysiol 2011;34:269-277
  14. Scheinman MM, Huang S. The 1998 NASPE prospect